Table 3. Factors significantly affecting compliance with clinical guideline recommendations.
| Patient or Clinical Characteristic | Guideline Recommendation | p value | |
| Exercise (n = 195) | |||
| Compliant (n = 70) | Non-compliant (n = 125) | ||
| Age (Median, IQR) | 79 (71–84) | 82 (75–86) | 0.036 |
| Enrolment in heart failure program | 33 (47%) | 25 (20%) | <0.001 |
| IRERs determined | 68 (97%) | 107 (86%) | 0.012 |
| Number of IRERs (Mean ± SD) | 24±10 | 17±11 | <0.001 |
| Number of appointments (Median, IQR) | 6 (4–11) | 3 (2–7) | <0.001 |
| Heart failure education (n = 226) | |||
| Compliant (n = 170) | Non-compliant (n = 56) | ||
| Enrolment in heart failure program | 73 (43%) | 1 (2%) | <0.001 |
| IRERs determined | 167 (98%) | 39 (70%) | <0.001 |
| Number of IRERs (Mean ± SD) | 24±20 | 10±9 | <0.001 |
| Numbers of appointments (Median, IQR) | 5 (3–10) | 2 (1–3) | <0.001 |
| Management by a cardiologist | 48 (28%) | 4 (7%) | 0.001 |
| Lives alone | 54 (32%) | 28 (50%) | 0.017 |
| Influenza vaccination (n = 208) | |||
| Compliant (n = 170) | Non-compliant (n = 38) | ||
| Age (Median, IQR) | 80 (78–86) | 79 (69–84) | 0.02 |
| Enrolment in heart failure program | 59 (35%) | 4 (11%) | 0.003 |
| IRERs determined | 161 (95%) | 27 (71%) | <0.001 |
| Number of IRERs (Mean ± SD) | 22±10 | 11±11 | <0.001 |
| Numbers of appointments (Median, IQR) | 5 (3–10) | 2 (1–3) | <0.001 |
| Pneumococcal vaccination (n = 183) | |||
| Compliant (n = 116) | Non-compliant (n = 67) | ||
| IRERs determined | 108 (93%) | 55 (82%) | 0.027 |
| Number of IRERs (Mean ± SD) | 24±10 | 17±11 | <0.001 |
| Numbers of appointments (Median, IQR) | 5 (3–11) | 3 (2–5) | <0.001 |
| Anticoagulation for AF (n = 79) | |||
| Compliant (n = 69) | Non-compliant (n = 10) | ||
| Age (Median, IQR) | 81 (76–85) | 85 (81–94) | 0.025 |
| Number of IRERs (Mean ± SD) | 20±11 | 9±9 | 0.004 |
| Meet HbA1c target in diabetes (n = 114) | |||
| Compliant (n = 92) | Non-compliant (n = 22) | ||
| IRERs determined | 90 (98%) | 15 (68%) | <0.001 |
| Number of IRERs (Mean ± SD) | 25±9 | 17±13 | 0.011 |
| Numbers of appointments (Median, IQR) | 5.5 (3–11) | 3 (1–6.3) | 0.021 |
| Lipids to target in diabetes (n = 68) | |||
| Compliant (n = 50) | Non-compliant (n = 18) | ||
| IRERs determined | 46 (92%) | 13 (72%) | 0.048 |
| Number of IRERs (Mean ± SD) | 25±11 | 15±12 | 0.007 |
| Numbers of appointments (Median, IQR) | 6 (2.8–11) | 3 (1.8–4.3) | 0.028 |
| Blood pressure to target in diabetes (n = 100) | |||
| Compliant (n = 91) | Non-compliant (n = 9) | ||
| IRERs determined | 85 (93%) | 6 (67%) | 0.033 |
| Eye checked in diabetes (n = 69) | |||
| Compliant (n = 24) | Non-compliant (n = 45) | ||
| IRERs determined | 24 (100%) | 36 (80%) | 0.022 |
| Management by a cardiologist | 46% | 20% | 0.03 |
| Lipid lowering therapy in ischemic heart disease (n = 94) | |||
| Compliant (n = 81) | Non-compliant (n = 13) | ||
| Age (Median, IQR) | 79 (74.5–83) | 83 (79–88.5) | 0.014 |
IRERs, individualised reconciled evidence-based recommendations.